Cargando…
Serum microRNAs as biomarkers for recurrence in melanoma
BACKGROUND: Identification of melanoma patients at high risk for recurrence and monitoring for recurrence are critical for informed management decisions. We hypothesized that serum microRNAs (miRNAs) could provide prognostic information at the time of diagnosis unaccounted for by the current staging...
Autores principales: | Friedman, Erica B, Shang, Shulian, de Miera, Eleazar Vega-Saenz, Fog, Jacob Ulrik, Teilum, Maria Wrang, Ma, Michelle W, Berman, Russell S, Shapiro, Richard L, Pavlick, Anna C, Hernando, Eva, Baker, Adam, Shao, Yongzhao, Osman, Iman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479021/ https://www.ncbi.nlm.nih.gov/pubmed/22857597 http://dx.doi.org/10.1186/1479-5876-10-155 |
Ejemplares similares
-
Deletion of PTENP1 pseudogene in human melanoma
por: Poliseno, Laura, et al.
Publicado: (2011) -
Hedgehog Pathway Blockade Inhibits Melanoma Cell Growth in Vitro and in Vivo
por: O’Reilly, Kathryn E., et al.
Publicado: (2013) -
Melanoma risk loci as determinants of melanoma recurrence and survival
por: Rendleman, Justin, et al.
Publicado: (2013) -
Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapy
por: Moogk, Duane, et al.
Publicado: (2014) -
The Novel Gamma Secretase Inhibitor RO4929097 Reduces the Tumor Initiating Potential of Melanoma
por: Huynh, Chanh, et al.
Publicado: (2011)